Shenzhen YuceBio Technology Co., Ltd. has many years of experience in the fields of tumor bio-information analysis, database construction, service delivery, and personalized medical data interpretation. The Company's existing core patents are centered on the technical route of "precise assay of immunotherapy medication markers → precise interpretation of immunotherapy medication markers → guidance for the application of immunotherapy medication", forming a patent protection network bolstered by the "neoantigen assay and validation technology", so that the Company's diagnosis and testing products for tumor immunotherapy medication have core competitiveness in the market, laying the foundation for the Company's leading position in the field of precise immunodiagnosis and treatment of tumors.

As of December 31, 2020, 28 invention patent applications have been filed, among which 7 have been authorized. The Company has obtained 24 software copyrights and registered 38 trademarks.